Clinical trial
Observational Study of the HemoCept Device During Right Heart Catheterization at Boulder Heart
NCT07224906 is registered in ClinicalTrials.gov with HemoCept Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observational Study of the HemoCept Device During Right Heart Catheterization at Boulder Heart
- Lead sponsor
- HemoCept Inc.
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- December 1, 2025
- Completion date
- January 31, 2027
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
congestive heart failure(chf), pulmonary hypertension, valve disease, heart